We are live on ! Find out more
WCBA

Weaver C. Barksdale & Associates Portfolio holdings

AUM $105M
1-Year Est. Return 13.81%
This Fund
S&P 500
This Quarter Est. Return
+9.47%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
10 Year Est. Return
AUM
$111M
AUM Growth
+$5.64M
Cap. Flow
-$3.19M
Cap. Flow %
-2.88%
Top 10 Hldgs %
22.16%
Holding
62
New
Increased
3
Reduced
57
Closed

Top Buys

Rank Stock Value
1
SJM icon
J.M. Smucker
SJM
+$643K
2
TGT icon
Target
TGT
+$234K
3
KR icon
Kroger
KR
+$137K

Top Sells

Rank Stock Value
1
AFL icon
Aflac
AFL
+$400K
2
MSFT icon
Microsoft
MSFT
+$164K
3
AVGO icon
Broadcom
AVGO
+$92.8K
4
ORI icon
Old Republic International
ORI
+$92.6K
5
GD icon
General Dynamics
GD
+$87.6K

Sector Composition

Rank Sector Weight
1 Financials 22.16%
2 Healthcare 13.3%
3 Industrials 11.84%
4 Technology 9.38%
5 Energy 8.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDT icon
51
Medtronic
MDT
$116B
$1.29M 1.16%
14,298
-441
-3% -$37.1K
JNJ icon
52
Johnson & Johnson
JNJ
$626B
$1.24M 1.11%
7,628
-405
-5% -$64.5K
OHI icon
53
Omega Healthcare
OHI
$13.8B
$1.22M 1.1%
29,916
-1,108
-4% -$41.9K
AES icon
54
AES
AES
$10.5B
$1.19M 1.07%
59,348
-2,270
-4% -$40.2K
CVS icon
55
CVS Health
CVS
$120B
$1.07M 0.96%
17,007
-627
-4% -$36.6K
BMY icon
56
Bristol-Myers Squibb
BMY
$130B
$1.01M 0.91%
19,580
-1,038
-5% -$48.7K
TFC icon
57
Truist Financial
TFC
$63.9B
$1.01M 0.91%
23,519
-903
-4% -$38.1K
BEN icon
58
Franklin Resources
BEN
$16.9B
$987K 0.89%
49,007
-1,872
-4% -$40.3K
PFE icon
59
Pfizer
PFE
$152B
$925K 0.83%
31,961
-1,691
-5% -$49.3K
TROW icon
60
T. Rowe Price
TROW
$24.3B
$867K 0.78%
7,959
-301
-4% -$33K
CAH icon
61
Cardinal Health
CAH
$56.3B
$692K 0.62%
6,258
CI icon
62
Cigna
CI
$72.4B
$644K 0.58%
1,859

Similar funds

Weaver C. Barksdale & Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Weaver C. Barksdale & Associates held 62 positions worth $111M, up 5.4% from $105M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 0%. Weaver C. Barksdale & Associates opened no new positions and made no exits, leaving the 62-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.

  • Weaver C. Barksdale & Associates added most to J.M. Smucker in Q3 2024, an estimated $643K increase.
  • Weaver C. Barksdale & Associates's biggest Q3 2024 reduction was Aflac, cutting an estimated $400K.
  • Weaver C. Barksdale & Associates's ten largest holdings make up 22% of its $111M portfolio in Q3 2024.
  • Weaver C. Barksdale & Associates opened 0 new positions and closed 0 in Q3 2024.
  • Weaver C. Barksdale & Associates's portfolio value rose 5.4% quarter-over-quarter to $111M.

Based on Weaver C. Barksdale & Associates's 13F filing for Q3 2024, filed 13 Nov 2024.